Functions of cannabinoid receptors in the hippocampus

Neuropharmacology

Volumn 42, Issue 8, 2002, Pages 993-1007

  Davies, S N ^a   Pertwee, R G ^a   Riedel, G ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Cannabinoid; Hippocampus

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; 4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL]BENZONITRILE; 4 AMINOBUTYRIC ACID; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; AM 374; AM 381; ANANDAMIDE; ARACHIDONYL 2' CHLOROETHYLAMIDE; ARACHIDONYLCYCLOPROPYLAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; DEXANABINOL; DRONABINOL; GUANINE NUCLEOTIDE BINDING PROTEIN; L 759633; L 759656; METABOTROPIC RECEPTOR; METHANANDAMIDE; N (4 HYDROXY 2 METHYLPHENYL)ARACHIDONAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; O 0812; O 1812; RIMONABANT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR;

AMNESIA; BRAIN FUNCTION; COGNITION; DEPOLARIZATION; DRUG EFFECT; DRUG EFFICACY; DRUG SELECTIVITY; GABAERGIC TRANSMISSION; HIPPOCAMPUS; HUMAN; LEARNING; LONG TERM POTENTIATION; MEMBRANE CONDUCTANCE; MEMBRANE CURRENT; MEMORY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SECOND MESSENGER; SYNAPTIC TRANSMISSION;

ANIMALS; CANNABINOIDS; COGNITION; ENDOCANNABINOIDS; HIPPOCAMPUS; HUMANS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 0036068317     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00060-6     Document Type: Review

References (144)

1. Cannabinoid CB1 receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo
2. 9-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: A microdialysis study
3. Retrograde signalling in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells
4. Cannabinoid receptor mediated inhibition of excitatory synaptic transmission in the rat hippocampal slice is developmentally regulated
5. The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice
6. Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices
7. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices
8. Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial defects produced by cannabinoids
9. Effects of chronic marijuana use in human cognition
10. Cannabinoid-induced alterations in regional cerebral blood flow in the rat
11. Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors
12. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain
13. Regional differences in cannabinoid receptor/G-protein coupling in rat brain
14. SR141716A antagonizes the disruptive effects of cannabinoid ligands on learning in rats
15. Control of pain initiation by endogenous cannabinoids
16. 9-tetrahydrocannabinol in rats
17. The effects of anandamide on memory consolidation in mice involve both D1 and D2 dopamine receptors
18. Strain-dependent effects of anandamide on memory consolidation in mice are antagonized by naltrexone
19. 9-tetrahydrocannabinol
20. Effects of anandamide on cannabinoid receptors in rat brain membranes
21. The actions of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice
22. Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice
23. A receptor-mediated responses in a grease-gap recording preparation of the rat hippocampal slice
24. The nature of storage deficits and state-dependent retrieval under marihuana
25. 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice
26. Cannabinoids modulate potassium current in cultured cultured hippocampal neurons
27. Cannabinoids modulate voltage sensitive potassium A-current in hippocampal neurons via a cAMP-dependent process
28. Complete adaptation to the memory disruptive effects of delta-9-THC following 35 days of exposure
29. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: Inhibitors of anandamide uptake with negligible capsaicin-like activity
30. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor
31. Biosynthesis and inactivation of endocannabinoids: Relevance to their proposed role as neuromodulators
32. Highly selective CB1 cannabinoid receptor ligands and novel CB1/VR1 vanilloid receptor "hybrid" ligands
33. 2 receptor-mediated actions of anandamide in mouse brain
34. Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action
35. Learning impairment produced in rats by the cannabinoid agonist HU210 in a water-maze task
36. Cognitive correlates of long-term cannabis use in Costa Rican men
37. Inhibition of hippocampal acetylcholine release by cannabinoids: Reversal by SR141716A
38. Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR141716A
39. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A
40. Large receptor reserve for cannabinoid actions in the central nervous system
41. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices
42. Effect of the cannabinoid receptor spect agent, AM 281, on hippocampal acetylcholine release from rat brain slices
43. Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes
44. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations
45. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus
46. Role of cannabinoid receptors in memory storage
47. Cannabinoids, hippocampal function and memory
48. Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats
49. Role of cyclic-AMP-dependent protein kinase in cannabinoid receptor modulation of potassium A-curreny in cultured rat hippocampal-neurons
50. HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor
51. Cholecystokinin receptors and memory - A radial maze study
52. Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study
53. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats. Alterations in short-term memory associated with changes in task specific firing of hippocampal cells
54. The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes
55. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1)
56. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus
57. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons
58. Functional expression of cell surface cannabinoid CB1 receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons
59. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
60. 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic utilization and impairs spatial working memory in the rat: Blockade of dopaminergic effects by HA966
61. The anandamide transport inhibitor AM404 is an agonist at the rat vanilloid receptor (VR1)
62. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain
63. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice
64. Gabaergic interneurons are the targets of cannabinoid actions in the human hippocampus
65. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axonal terminals of specific hippocampal interneurons
66. Head group analogs of arachidonylethanolamide, the endogenous cannabinoid ligand
67. Structure-activity relationships of anandamide, an endogenous cannabinoid ligand
68. Cannabinoid receptor activation in CA1 pyramidal cells in adult rat hippocampus
69. Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells
70. Endocannabinoids as cardiovascular modulators
71. 9-tetrahydrocannabinol: Possible mediation by glucocorticoid systems
72. Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2
73. SR141716A enhances spatial memory assessed in a radial-arm maze task in rats
74. Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats
75. 9-tetrahydrocannabinol impairs spatial memory through cannabinoid receptor mechanism
76. Anandamide hydrolysis by human cells in culture and brain
77. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors
78. The endogenous cannabinoid receptor agonist impairs memory in rats
79. 9-tetrahydrocannabinol or anandamide
80. Activation of the cannabinoid receptor by Delta(9)-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus
81. Effects of cannabinoid receptor antagonist SR141716A on the behavior of pigeons and rats
82. Cannabis: Effects on memory and the cholinergic limbic system
83. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons
84. 9-tetrahydocannabinol on short-term memory in the rat
85. Effects of cannabinoids on the immune system and central nervous system - Therapeutic implications
86. Aergic transmission in hippocampal CA1
87. Protein kinase-dependent phosphorylation and cannabinoid receptor modulation of potassium A current (I-A) in cultured rat hippocampal neurons
88. Cannabinoid receptors differentially modulate potassium A and D currents in hippocampal neurons in culture
89. Molecular characterization of a peripheral receptor for cannabinoids
90. Anandamide modulates sleep and memory in rats
91. Memory consolidation, retrograde amnesia and the hippocampal complex
92. Reversible effects of acute and long-term administration of Δ-9-tetrahydrocannabinol (THC) on memory in the rat
93. 9tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration
94. 9tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze
95. The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus, in vitro
96. Anti-ischemic and cognition-enhancing properties of NNC-711, a γ-aminobutyric acid reuptake inhibitor
97. Endogenous cannabinoids mediate retrograde signals from depolarised postsynaptic neurons to presynaptic terminals
98. Hippocampal lesions and active avoidance
99. Hippocampal connections and spatial discrimination
100. Correlation between cannabinoid mediated effects on paired pulse depression and induction of long term potentiation in the rat hippocampal slice
101. The actions of cannabis in man
102. Pharmacology of cannabinoid CB1 and CB2 receptors
103. Pharmacology of cannabinoid receptor ligands
104. Cannabinoid receptor ligands: Clinical and neuropharmacological considerations, relevant to future drug discovery and development
105. Cannabinoid receptors and pain
106. Cannabinoid receptors and their ligands
107. The ligand that came from within
108. Structural determinants for recognition and translocation by the anandamide transporter
109. Postsynaptic spike firing reduces synaptic GABA(A) responses in hippocampal pyramidal cells
110. Metabolic mapping of the effects of Win 55,212-2 intravenous administration in the rat
111. 1 receptor knock-out mice
112. Reversal neural inactivation reveals hippocampal participation in several memory processes
113. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
114. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor
115. The activation of cannabinoid receptors in striatonigral gabaergic neurons inhibited GABA uptake
116. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630
117. Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC)
118. Modulation of transmitter release via presynaptic cannabinoid receptors
119. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus
120. Cannabinoids decrease the K+ M-current in hippocampal CA1 neurons
121. Cannabinoid modulation of neuronal activity in adult rat hippocampus
122. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures
123. The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons
124. Memory and the hippocampus: A synthesis from findings with rats, monkeys and humans
125. A second endogenous cannabinoid that modulates long-term potentiation
126. Residual effects of prolonged cannabis treatment on shuttle-box avoidance in the rat
127. Learning impairment in the radial-arm maze following prolonged cannabis treatment in rats
128. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons
129. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum
130. New perspectives on enigmatic vanilloid receptors
131. Inhibition of long-term potentiation in rat hippocampal slices by anadamide and WIN55,212-2: Reversal by SR141716A, a selective antagonist of CB1 cannabinoid receptors
132. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR141716
133. 1 receptors are localized primarily on cholecystokinin-containing gabaergic interneurons in the rat hippocampal formation
134. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons
135. The fatty acid amide hydrolase (FAAH)
136. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus
137. DSI promotes LTP induction in CA1
138. 9THC on spatial reference and working memory in mice
139. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
140. Presynaptic specificity of endocannabinoid signaling in the hippocampus
141. The anandamide transport inhibitor AM404 activates vanilloid receptors
142. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide